(Q40977739)

25 September 2017

1 reference

title

Outpatient anticoagulation issues for the primary care physician (English)

1 reference

25 September 2017

1 reference

Spandorfer JM

1

1 reference

25 September 2017

Merli GJ

series ordinal

2

1 reference

25 September 2017

language of work or name

1 reference

1 March 1996

1 reference

Medical Clinics of North America

25 September 2017

published in

1 reference

25 September 2017

volume

80

1 reference

25 September 2017

issue

2

1 reference

25 September 2017

page(s)

475-491

1 reference

Low 1,25-dihydroxyvitamin D in heparin-induced osteopenia

25 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970449-1

Very low doses of warfarin can prevent thrombosis in central venous catheters. A randomized prospective trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970449-1

Anticoagulants in older patients. A safety perspective

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970449-1

The effect of low-dose warfarin on the risk of stroke in patients with nonrheumatic atrial fibrillation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970449-1

Nonrheumatic atrial fibrillation. Risk of stroke and role of antithrombotic therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970449-1

Antithrombotic agents in coronary artery disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970449-1

Optimal oral anticoagulant therapy in patients with mechanical heart valves.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970449-1

Acute gastrointestinal haemorrhage in anticoagulated patients: diagnoses and response to endoscopic treatment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970449-1

Antithrombotic therapy in peripheral arterial occlusive disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970449-1

Canadian atrial fibrillation anticoaguiation (CAFA) study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970449-1

7 January 2021

Alopecia from coumarin

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970449-1

The significance of hematuria in the anticoagulated patient

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970449-1

Osteoporotic fractures and the recurrence of thromboembolism during pregnancy and the puerperium in 184 women undergoing thromboprophylaxis with heparin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970449-1

Warfarin-induced skin necrosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970449-1

Optimal oral anticoagulant therapy in patients with nonrheumatic atrial fibrillation and recent cerebral ischemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970449-1

Warfarin in the prevention of stroke associated with nonrheumatic atrial fibrillation. Veterans Affairs Stroke Prevention in Nonrheumatic Atrial Fibrillation Investigators

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970449-1

Risk factors for complications of chronic anticoagulation. A multicenter study. Warfarin Optimized Outpatient Follow-up Study Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970449-1

The natural history of idiopathic dilated cardiomyopathy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970449-1

Ocular surgery on patients receiving long-term warfarin therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970449-1

Effect of age upon the induction and maintenance of anticoagulation with warfarin.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970449-1

Cost-justification of a clinical pharmacist-managed anticoagulation clinic

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970449-1

Aging and the anticoagulant response to warfarin therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970449-1

The international normalized ratio. A guide to understanding and correcting its problems

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970449-1

Warfarin Sodium versus Low-Dose Heparin in the Long-Term Treatment of Venous Thrombosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970449-1

Different intensities of oral anticoagulant therapy in the treatment of proximal-vein thrombosis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970449-1

Risk factors for intracranial hemorrhage in outpatients taking warfarin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970449-1

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970449-1

The management of thrombosis in the antiphospholipid-antibody syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970449-1

Dermatitis induced by warfarin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970449-1

Need for long-term anticoagulant treatment in symptomatic calf-vein thrombosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970449-1

Anticoagulant-related bleeding: clinical epidemiology, prediction, and prevention

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970449-1

Major bleeding in outpatients treated with warfarin: incidence and prediction by factors known at the start of outpatient therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970449-1

Bleeding in outpatients treated with warfarin: relation to the prothrombin time and important remediable lesions.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970449-1

Antithrombotic therapy in atrial fibrillation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970449-1

Comparison of efficacy and safety of low molecular weight heparins and unfractionated heparin in initial treatment of deep venous thrombosis: a meta-analysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970449-1

Hemorrhagic complications of anticoagulant treatment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970449-1

Double-blind randomised trial of a very-low-dose warfarin for prevention of thromboembolism in stage IV breast cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970449-1

Answers to the antiphospholipid-antibody syndrome?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970449-1

Update. Deep vein thrombosis and pulmonary embolism prophylaxis in orthopedic surgery.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970449-1

Placebo-controlled, randomised trial of warfarin and aspirin for prevention of thromboembolic complications in chronic atrial fibrillation. The Copenhagen AFASAK study.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970449-1

Thyrotoxicosis, atrial fibrillation, and embolism, revisited

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970449-1

Evaluation of the gastrointestinal tract in patients with iron-deficiency anemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970449-1

A comparison of six weeks with six months of oral anticoagulant therapy after a first episode of venous thromboembolism. Duration of Anticoagulation Trial Study Group.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970449-1

Complications of coronary stenting

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970449-1

Antithrombotic therapy in patients with mechanical and biological prosthetic heart valves

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970449-1

Stroke Prevention in Atrial Fibrillation Study. Final results

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970449-1

A comparison of aspirin with placebo in patients treated with warfarin after heart-valve replacement

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970449-1

Randomised comparison of two intensities of oral anticoagulant therapy after tissue heart valve replacement.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970449-1

Interactions of warfarin with drugs and food

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970449-1

Outpatient use of a portable international normalized ratio/prothrombin time monitor.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970449-1

Initiation of warfarin therapy: comparison of physician dosing with computer-assisted dosing

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970449-1

Temporary discontinuation of warfarin therapy: changes in the international normalized ratio

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970449-1

Gastrointestinal bleeding in patients receiving long-term anticoagulant therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970449-1

Epidemiologic assessment of chronic atrial fibrillation and risk of stroke: The fiamingham Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970449-1

10.1016/S0025-7125(05)70449-1

7 January 2021

Identifiers

DOI

1 reference

25 September 2017

1 reference